Literature DB >> 20697270

Symptom distress and self-care strategies of colorectal cancer patients with diarrhea up to 3 months after surgery.

Li-Hui Pan1, Yun-Fang Tsai, Mei-Ling Chen, Reiping Tang, Chee-Jen Chang.   

Abstract

BACKGROUND: Diarrhea is common after colorectal surgery, but its severity and self-care methods have not been examined in depth.
OBJECTIVE: To understand changes in and factors influencing diarrhea distress and self-care strategies of patients 1 week and 1, 2, and 3 months after colorectal cancer surgery.
METHODS: For this descriptive, longitudinal study, 35 cancer patients were recruited from a teaching hospital in northern Taiwan. Data were collected in structured, one-on-one interviews at 1 week and 1, 2, and 3 months after surgery. Variance and effects of diarrhea distress and number of self-care strategies were analyzed by repeated-measures analysis of variance and generalized estimating equation. Effectiveness scores for self-care strategies were analyzed by Wilcoxon signed rank test.
RESULTS: Participants' overall level of diarrhea symptom distress was low. Distress level was highest 1 week after surgery, but gradually decreased thereafter. Over time after surgery, patients' frequency of using self-care strategies did not differ, but self-care strategies changed. Dietary modification and exercise were rated as the most effective strategies. Self-care information for hospitalized patients was primarily provided by medical personnel. The major factor affecting diarrhea distress was defecation frequency, and the major factors affecting self-care strategies were age, cancer stage, defecation frequency, and diarrhea distress.
CONCLUSION: Diarrhea distress level gradually decreased, and self-care strategies changed with time after colorectal cancer surgery. IMPLICATIONS FOR PRACTICE: Because health care personnel were the primary source of self-care information for hospitalized patients after colorectal cancer surgery, nurses should use these findings to provide supportive treatment and educate patients and their family members about the cause and severity of diarrhea. Such education should include treatment-induced adverse effects as the basis for treating diarrhea.

Entities:  

Mesh:

Year:  2011        PMID: 20697270     DOI: 10.1097/NCC.0b013e3181e3ca21

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  5 in total

1.  The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors.

Authors:  Erin E Kent; Sandra A Mitchell; Ingrid Oakley-Girvan; Neeraj K Arora
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

2.  Consequences, control and appraisal: cues and barriers to engaging in self-management among people affected by colorectal cancer - a secondary analysis of qualitative data.

Authors:  Lisa A Kidd
Journal:  Health Expect       Date:  2012-05-11       Impact factor: 3.377

3.  Chronic disease management perspectives of colorectal cancer survivors using the Veterans Affairs healthcare system: a qualitative analysis.

Authors:  Leah L Zullig; Karen M Goldstein; Hayden B Bosworth; Sara M Andrews; Susanne Danus; George L Jackson; Dawn Provenzale; Morris Weinberger; Michael J Kelley; Corrine I Voils
Journal:  BMC Health Serv Res       Date:  2018-03-09       Impact factor: 2.655

4.  The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer.

Authors:  Helena Harder; Valerie M Shilling; Shirley F May; David Cella; Peter Schmid; Lesley J Fallowfield
Journal:  Breast Cancer Res Treat       Date:  2020-07-27       Impact factor: 4.872

5.  Long-term effects of neoadjuvant chemoradiotherapy followed by sphincter-preserving resection on anal sphincter function in relation to quality of life among locally advanced rectal cancer patients: a cross-sectional analysis.

Authors:  Zerrin Ozgen; Sevgi Ozden; Beste M Atasoy; Hazan Ozyurt; Rasim Gencosmanoglu; Nese Imeryuz
Journal:  Radiat Oncol       Date:  2015-08-12       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.